AI MARKET SCANNING

Veru Inc

AVG HISTORICAL GAP -1.72%
MAX GAP RECORD -13.26%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $VERU
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 10, 2026 Earnings Release 2026-08-10 (BEFORE OPEN)
+5.15%
May 13, 2026 Earnings Release 2026-05-13 (BEFORE OPEN)
+0.88%
Feb 11, 2026 Earnings Release 2026-02-11 (BEFORE OPEN)
+0.43%
Dec 17, 2025 Earnings Release 2025-12-17 (BEFORE OPEN)
+0.41%
Aug 12, 2025 Earnings Release 2025-08-12 (BEFORE OPEN)
-9.75%
May 07, 2025 Earnings Release 2025-05-07 (BEFORE OPEN)
+0.00%
Feb 13, 2025 Earnings Release 2025-02-13 (BEFORE OPEN)
-3.64%
Dec 16, 2024 Earnings Release 2024-12-16 (AFTER CLOSE)
-3.80%

VOLATILITY & GAP BIAS

AVG GAP MOVE 3.5%
Bullish Gaps (3)
Bearish Gaps (4)
Neutral / Flat (5)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $VERU

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Veru, Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines and treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. The company was founded by William R. Gargiulo, Jr. and O. B. Parrish in 1971…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗